Assyro AI

FDA Orange Book · active-ingredient family

Hydrochlorothiazide; quinapril hydrochloride

Hydrochlorothiazide; quinapril hydrochloride is approved as 1 brand and 6 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:ACCURETIC · NDA 020125

1

Brand (NDA)

6

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet

ProductApplicantApplicationTEApproved
ACCURETICRLD×3PFIZER PHARMSNDA 020125Dec 28, 1999

Generic (ANDA) products (6)

ProductApplicantApplicationTEApproved
QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE×3APOTEXANDA 091524Mar 12, 2013
QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE×3INVAGEN PHARMSANDA 201356Apr 20, 2011
QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE×3SUN PHARM INDS LTDANDA 078211Mar 04, 2009
QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE×3AUROBINDO PHARMAANDA 078450ABAug 24, 2007
QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE×3PHARMOBEDIENTANDA 077093Mar 28, 2005
QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE×3CHARTWELL RXANDA 076374ABMar 31, 2004

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Hydrochlorothiazide; quinapril hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.